UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.659

Sortiert nach

RENAL nephrometry score predicts surgical outcomes of laparoscopic partial nephrectomy

BJU international, 2011-09, Vol.108 (6), p.876-881

2011

Volltextzugriff (PDF)

Whole-Transcriptome profiling of formalin-fixed, paraffin-embedded renal cell carcinoma by RNA-seq

BMC genomics, 2014-12, Vol.15 (1), p.1087-1087, Article 1087

2014

Volltextzugriff (PDF)

Stimulation of antitumor immunity by FoxP3-targeting PROTAC

Biomedicine & pharmacotherapy, 2023-07, Vol.163, p.114871-114871, Article 114871

2023

Volltextzugriff (PDF)

A comparison of Ku0063794, a dual mTORC1 and mTORC2 inhibitor, and temsirolimus in preclinical renal cell carcinoma models

PloS one, 2013-01, Vol.8 (1), p.e54918

2013

Volltextzugriff (PDF)

Percutaneous Biopsy of Renal Cell Carcinoma Underestimates Nuclear Grade

Urology (Ridgewood, N.J.), 2010-09, Vol.76 (3), p.610-613

2010

Volltextzugriff (PDF)

Robot-Assisted Radical Cystectomy and Pelvic Lymph Node Dissection: Initial Experience at Roswell Park Cancer Institute

Urology (Ridgewood, N.J.), 2007-03, Vol.69 (3), p.469-474

2007

Volltextzugriff (PDF)

Recognizing the Continuous Nature of Expression Heterogeneity and Clinical Outcomes in Clear Cell Renal Cell Carcinoma

Scientific reports, 2017-08, Vol.7 (1), p.7342-10, Article 7342

2017

Volltextzugriff (PDF)

Surveillance after radical or partial nephrectomy for localized renal cell carcinoma and management of recurrent disease

Urologic Clinics of North America, 2003-11, Vol.30 (4), p.843-852

2003

Volltextzugriff (PDF)

Detection of live circulating tumor cells by a class of near-infrared heptamethine carbocyanine dyes in patients with localized and metastatic prostate cancer

PloS one, 2014-02, Vol.9 (2), p.e88967-e88967

2014

Volltextzugriff (PDF)

Learning curves for robot-assisted and laparoscopic partial nephrectomy

Journal of endourology, 2015-03, Vol.29 (3), p.297

2015

Volltextzugriff (PDF)

Presurgical sunitinib reduces tumor size and may facilitate partial nephrectomy in patients with renal cell carcinoma

Urologic oncology, 2015-03, Vol.33 (3), p.112.e15-112.e21

2015

Volltextzugriff (PDF)

Cigarette smoking is an independent risk factor for type 2 diabetes: a four-year community-based prospective study

Clinical endocrinology (Oxford), 2009-11, Vol.71 (5), p.679-685

2009

Volltextzugriff (PDF)

Genetic Landscape of Prostate Cancer Conspicuity on Multiparametric Magnetic Resonance Imaging: A Systematic Review and Bioinformatic Analysis

European urology open science (Online), 2020-07, Vol.20, p.37-47

2020

Volltextzugriff (PDF)

An Alternative Option for Gender-Affirming Revision Vaginoplasty: The Tubularized Urachus-Peritoneal Hinge Flap

Sexual medicine, 2022-12, Vol.10 (6), p.100572-100572, Article 100572

2022

Volltextzugriff (PDF)

Using Protein Expressions to Predict Survival in Clear Cell Renal Carcinoma

Clinical cancer research, 2004-08, Vol.10 (16), p.5464-5471

2004

Volltextzugriff (PDF)

Cytoreductive nephrectomy for favorable risk patients with metastatic renal cell carcinoma? No, cytoreductive nephrectomy should no longer be routinely performed

Current opinion in urology, 2020-09, Vol.30 (5), p.743

Kim, Hyung L

2020

Volltextzugriff (PDF)

Increasing Age and Treatment Modality Are Predictors for Subsequent Diagnosis of Bladder Cancer Following Prostate Cancer Diagnosis

International journal of radiation oncology, biology, physics, 2010-11, Vol.78 (4), p.1086-1094

2010

Volltextzugriff (PDF)

Prognostic Significance of Venous Thrombus in Renal Cell Carcinoma. Are Renal Vein and Inferior Vena Cava Involvement Different?

The Journal of urology, 2004-02, Vol.171 (2), p.588-591

2004

Volltextzugriff (PDF)

Centromere protein F (CENPF), a microtubule binding protein, modulates cancer metabolism by regulating pyruvate kinase M2 phosphorylation signaling

Cell cycle (Georgetown, Tex.), 2018-12, Vol.17 (24), p.2802-2818

2018

Volltextzugriff (PDF)

Multiparametric magnetic resonance imaging localizes established extracapsular extension of prostate cancer

Urologic oncology, 2015-03, Vol.33 (3), p.109.e15-109.e22

2015

Volltextzugriff (PDF)

Multiparametric MRI Improves Accuracy of Clinical Nomograms for Predicting Extracapsular Extension of Prostate Cancer

Urology (Ridgewood, N.J.), 2015-08, Vol.86 (2), p.332-337

2015

Volltextzugriff (PDF)

The lymph node yield during robot‐assisted radical cystectomy

BJU international, 2008-07, Vol.102 (2), p.231-234

2008

Volltextzugriff (PDF)

Online physician ratings fail to predict actual performance on measures of quality, value, and peer review

Journal of the American Medical Informatics Association : JAMIA, 2018-04, Vol.25 (4), p.401-407

2018

Volltextzugriff (PDF)

Cholesterol-Lowering Intervention Decreases mTOR Complex 2 Signaling and Enhances Antitumor Immunity

Clinical cancer research, 2022-01, Vol.28 (2), p.414-424

2022

Volltextzugriff (PDF)

PAK4 inhibition improves PD1 blockade immunotherapy in prostate cancer by increasing immune infiltration

Cancer letters, 2023-02, Vol.555, p.216034-216034, Article 216034

2023

Volltextzugriff (PDF)

1 – 25 von 1.659

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.498)
Mit Volltextzugriff
(1.461)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(11)

Menü

Weitere Dienste

Einstellungen

RENAL nephrometry score predicts surgical outcomes of laparoscopic partial nephrectomy

Whole-Transcriptome profiling of formalin-fixed, paraffin-embedded renal cell carcinoma by RNA-seq

Stimulation of antitumor immunity by FoxP3-targeting PROTAC

A comparison of Ku0063794, a dual mTORC1 and mTORC2 inhibitor, and temsirolimus in preclinical renal cell carcinoma models

Percutaneous Biopsy of Renal Cell Carcinoma Underestimates Nuclear Grade

Robot-Assisted Radical Cystectomy and Pelvic Lymph Node Dissection: Initial Experience at Roswell Park Cancer Institute

Recognizing the Continuous Nature of Expression Heterogeneity and Clinical Outcomes in Clear Cell Renal Cell Carcinoma

Surveillance after radical or partial nephrectomy for localized renal cell carcinoma and management of recurrent disease

Detection of live circulating tumor cells by a class of near-infrared heptamethine carbocyanine dyes in patients with localized and metastatic prostate cancer

Learning curves for robot-assisted and laparoscopic partial nephrectomy

Presurgical sunitinib reduces tumor size and may facilitate partial nephrectomy in patients with renal cell carcinoma

Cigarette smoking is an independent risk factor for type 2 diabetes: a four-year community-based prospective study

Genetic Landscape of Prostate Cancer Conspicuity on Multiparametric Magnetic Resonance Imaging: A Systematic Review and Bioinformatic Analysis

An Alternative Option for Gender-Affirming Revision Vaginoplasty: The Tubularized Urachus-Peritoneal Hinge Flap

Using Protein Expressions to Predict Survival in Clear Cell Renal Carcinoma

Cytoreductive nephrectomy for favorable risk patients with metastatic renal cell carcinoma? No, cytoreductive nephrectomy should no longer be routinely performed

Increasing Age and Treatment Modality Are Predictors for Subsequent Diagnosis of Bladder Cancer Following Prostate Cancer Diagnosis

Prognostic Significance of Venous Thrombus in Renal Cell Carcinoma. Are Renal Vein and Inferior Vena Cava Involvement Different?

Centromere protein F (CENPF), a microtubule binding protein, modulates cancer metabolism by regulating pyruvate kinase M2 phosphorylation signaling

Multiparametric magnetic resonance imaging localizes established extracapsular extension of prostate cancer

Multiparametric MRI Improves Accuracy of Clinical Nomograms for Predicting Extracapsular Extension of Prostate Cancer

The lymph node yield during robot‐assisted radical cystectomy

Online physician ratings fail to predict actual performance on measures of quality, value, and peer review

Cholesterol-Lowering Intervention Decreases mTOR Complex 2 Signaling and Enhances Antitumor Immunity

PAK4 inhibition improves PD1 blockade immunotherapy in prostate cancer by increasing immune infiltration

Suchergebnisse filtern